This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Han, V K Articles by Lee, D C Search for Related Content PubMed PubMed Citation Articles by Han, V K Articles by Lee, D C

Expression of rat transforming growth factor alpha mRNA during development occurs predominantly in the maternal decidua.

ABSTRACT

Previous studies have shown that transforming growth factor alpha is expressed during rodent development. To establish the site(s) of transforming growth factor alpha mRNA expression during rat embryogensis, we performed in situ hybridization and Northern blot analyses on samples of embryonic and maternal tissues at various gestational ages. Our results indicate that the high levels of transforming growth factor alpha mRNA that are observed during early development are the result of expression in the maternal decidua and not in the embryo. Decidual expression appears to be induced after implantation, peaks at day 8, and then slowly declines through day 15 at which time the decidua is being resorbed. Expression of transforming growth factor alpha mRNA is highest in that region of the decidua adjacent to the embryo and is low or nondetectable in the uterus, placenta, and other maternal tissues. The developmentally regulated expression of transforming growth factor alpha mRNA in the decidua, together with the presence of epidermal growth factor receptors in this tissue, suggests that transforming growth factor alpha stimulates proliferation locally through an autocrine mechanism. Since epidermal growth factor receptors are present in the embryo and placenta, transforming growth factor alpha produced in the decidua may also act on these tissues through paracrine or endocrine mechanisms.

This article has been cited by other articles:

• Bifulco, G., Di Carlo, C., Caruso, M., Oriente, F., Di Spiezio Sardo, A., Formisano, P., Beguinot, F., Nappi, C. (2002). Glucose Regulates Insulin Mitogenic Effect by Modulating SHP-2 Activation and Localization in JAr Cells. J. Biol. Chem. 277: 24306-24314 [Abstract] [Full Text]  
• Keith Ho, H.-C., McGrath, K. E., Brodbeck, K. C., Palis, J., Schick, B. P. (2001). Serglycin Proteoglycan Synthesis in the Murine Uterine Decidua and Early Embryo. Biol. Reprod. 64: 1667-1676 [Abstract] [Full Text]  
• Aoyama, H., Kato, H., Dixon, D. (1997). Specificity of Antibodies Against Rodent Transforming Growth Factor-{{alpha}} Protein. J. Histochem. Cytochem. 45: 695-702 [Abstract] [Full Text]  
• Alexander, C., Hansell, E., Behrendtsen, O, Flannery, M., Kishnani, N., Hawkes, S., Werb, Z (1996). Expression and function of matrix metalloproteinases and their inhibitors at the maternal-embryonic boundary during mouse embryo implantation. Development 122: 1723-1736 [Abstract]  
• Luetteke, N C, Phillips, H K, Qiu, T H, Copeland, N G, Earp, H S, Jenkins, N A, Lee, D C (1994). The mouse waved-2 phenotype results from a point mutation in the EGF receptor tyrosine kinase.. Genes Dev. 8: 399-413 [Abstract]  
• Rappolee, D A, Sturm, K S, Behrendtsen, O, Schultz, G A, Pedersen, R A, Werb, Z (1992). Insulin-like growth factor II acts through an endogenous growth pathway regulated by imprinting in early mouse embryos.. Genes Dev. 6: 939-952 [Abstract]